Michael R. Minogue - 05 Aug 2021 Form 4 Insider Report for ABIOMED INC

Role: Chairman, President, CEO, Director
Signature: /s/ Marc A Began (by power of attorney)
Issuer symbol: N/A
Transactions as of: 05 Aug 2021
Net transactions value: -$7,950,832
Form type: 4
Filing time: 06 Aug 2021, 16:16:05 UTC
Previous filing: 23 Jun 2021
Next filing: 10 Aug 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABMD	Common Stock $.01 par value	Options Exercise	$578,750	+25,000	+12%	$23.15	236,635	05 Aug 2021	Direct	F5
transaction	ABMD	Common Stock $.01 par value	Sale	$5,065,599	-14,887	-6.3%	$340.27	221,748	05 Aug 2021	Direct	F6, F7
transaction	ABMD	Common Stock $.01 par value	Sale	$1,836,264	-5,378	-2.4%	$341.44	216,370	05 Aug 2021	Direct	F6, F8
transaction	ABMD	Common Stock $.01 par value	Sale	$457,211	-1,335	-0.62%	$342.48	215,035	05 Aug 2021	Direct	F6, F9
transaction	ABMD	Common Stock $.01 par value	Sale	$514,980	-1,500	-0.7%	$343.32	213,535	05 Aug 2021	Direct	F6, F10
transaction	ABMD	Common Stock $.01 par value	Sale	$172,665	-500	-0.23%	$345.33	213,035	05 Aug 2021	Direct	F6, F11
transaction	ABMD	Common Stock $.01 par value	Sale	$138,432	-400	-0.19%	$346.08	212,635	05 Aug 2021	Direct	F6, F12
transaction	ABMD	Common Stock $.01 par value	Sale	$344,430	-1,000	-0.47%	$344.43	211,635	05 Aug 2021	Direct	F6, F13
holding	ABMD	Common Stock $.01 par value						52,555	05 Aug 2021	By Trust - A
holding	ABMD	Common Stock $.01 par value						73,745	05 Aug 2021	By Trust - B
holding	ABMD	Common Stock $.01 par value						32,810	05 Aug 2021	By Trust - C
holding	ABMD	Common Stock $.01 par value						655	05 Aug 2021	By Trust - D
holding	ABMD	Common Stock $.01 par value						38,560	05 Aug 2021	By Trust - E
holding	ABMD	Common Stock $.01 par value						85,040	05 Aug 2021	By Trust - F

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ABMD	Stock Option (Right to Buy)	Disposed to Issuer	$0	-25,000	-42%	$0.000000	35,000	05 Aug 2021	Common stock	25,000	$23.15	Direct	F1, F2, F5
holding	ABMD	Stock Option (right to buy)						85,000	05 Aug 2021	Common Stock	0	$21.55	Direct	F2, F3
holding	ABMD	Stock Option (right to buy)						35,000	05 Aug 2021	Common Stock	0	$66.25	Direct	F2, F3
holding	ABMD	Stock Option (right to buy)						30,500	05 Aug 2021	Common Stock	0	$99.62	Direct	F3, F4
holding	ABMD	Stock Option (right to buy)						33,000	05 Aug 2021	Common Stock	0	$134.51	Direct	F3, F4
holding	ABMD	Stock Option (right to buy)						30,000	05 Aug 2021	Common Stock	0	$381.97	Direct	F3, F4
holding	ABMD	Stock Option (right to buy)						50,000	05 Aug 2021	Common Stock	0	$266.39	Direct	F3, F4
holding	ABMD	Stock Option (Right to Buy)						20,898	05 Aug 2021	Common Stock	0	$223.90	Direct	F3, F4
holding	ABMD	Stock Option (Right to Buy)						30,000	05 Aug 2021	Common Stock	0	$283.88	Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
F2	Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
F3	These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
F4	Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
F5	Exercise of stock options pursuant to reporting owners 10b5-1 plan.
F6	Sale of common stock pursuant to reporting owner's 10b5-1 plan.
F7	This price represents the sale price of the transactions on the reported date at $340.2661. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F8	This price represents the sale price of the transactions on the reported date at $341.4448. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F9	This price represents the sale price of the transactions on the reported date at $342.4849. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F10	This price represents the sale price of the transactions on the reported date at $3343.3223. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F11	This price represents the sale price of the transactions on the reported date at $345.3314. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F12	This price represents the sale price of the transactions on the reported date at $346.0750. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F13	This price represents the sale price of the transactions on the reported date at $344.4270. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.